A survey has found that there is strong consumer support for pharma manufacturers to disclose the carbon footprint of their medicines, amid rising public scrutiny of the e
AstraZeneca has said it will plant 200 million trees across six continents by 2030 in an effort to fight escalating rates of deforestation around the globe that is contrib
As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.
Jamie Phares, managing director, The Janssen Pharmaceutical Companies of Johnson & Johnson in the Gulf Cooperation Council (GCC), talks about how the healthcare industry needs to come t
AbbVie is preparing to file for accelerated approval of telisotuzumab vedotin (Teliso-V) as a treatment for some patients with lung cancer after the drug hit the mark in a
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio